These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24446192)

  • 1. Is the hypoglycemic action of vanadium compounds related to the suppression of feeding?
    Huang M; Wu Y; Wang N; Wang Z; Zhao P; Yang X
    Biol Trace Elem Res; 2014 Mar; 157(3):242-8. PubMed ID: 24446192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new salicylic acid-derivatized kojic acid vanadyl complex: synthesis, characterization and anti-diabetic therapeutic potential.
    Wei Y; Zhang C; Zhao P; Yang X; Wang K
    J Inorg Biochem; 2011 Aug; 105(8):1081-5. PubMed ID: 21726771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis.
    Mehdi MZ; Srivastava AK
    Arch Biochem Biophys; 2005 Aug; 440(2):158-64. PubMed ID: 16055077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, characterization and anti-diabetic therapeutic potential of a new benzyl acid-derivatized kojic acid vanadyl complex.
    Wei YB; Yang XD
    Biometals; 2012 Dec; 25(6):1261-8. PubMed ID: 23015214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-diabetic activity of new N,N-dimethylphenylenediamine-derivatized nitrilotriacetic acid vanadyl complexes.
    Niu X; Yang J; Yang X
    J Inorg Biochem; 2017 Dec; 177():291-299. PubMed ID: 28709620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Small Insulinomimetic Molecule Also Improves Insulin Sensitivity in Diabetic Mice.
    Mukherjee S; Chattopadhyay M; Bhattacharya S; Dasgupta S; Hussain S; Bharadwaj SK; Talukdar D; Usmani A; Pradhan BS; Majumdar SS; Chattopadhyay P; Mukhopadhyay S; Maity TK; Chaudhuri MK; Bhattacharya S
    PLoS One; 2017; 12(1):e0169809. PubMed ID: 28072841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
    Srivastava AK; Mehdi MZ
    Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
    Xie M; Gao L; Li L; Liu W; Yan S
    J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
    Willsky GR; Chi LH; Liang Y; Gaile DP; Hu Z; Crans DC
    Physiol Genomics; 2006 Aug; 26(3):192-201. PubMed ID: 16684804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM; Risovic V; Yuen VG; McNeill JH
    J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The vanadium compounds: chemistry, synthesis, insulinomimetic properties].
    Fedorova EV; Buriakina AV; Vorob'eva NM; Baranova NI
    Biomed Khim; 2014; 60(4):416-29. PubMed ID: 25249525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanadium (vanadyl sulfate). Monograph.
    Altern Med Rev; 2009 Jun; 14(2):177-80. PubMed ID: 19594227
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanadium compounds modulate PPARγ activity primarily by increasing PPARγ protein levels in mouse insulinoma NIT-1 cells.
    Zhao P; Yang X
    Metallomics; 2013 Jun; 5(7):836-43. PubMed ID: 23456093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin-mimetic property of vanadium compounds].
    Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
    Postepy Biochem; 2016; 62(1):60-65. PubMed ID: 28132446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Vanadyl Rosiglitazone, a New Insulin-Mimetic Vanadium Complexes, on Glucose Homeostasis of Diabetic Mice.
    Jiang P; Dong Z; Ma B; Ni Z; Duan H; Li X; Wang B; Ma X; Wei Q; Ji X; Li M
    Appl Biochem Biotechnol; 2016 Nov; 180(5):841-851. PubMed ID: 27240663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and anti-diabetic therapeutic potential of novel aminophenol-derivatized nitrilotriacetic acid vanadyl complexes.
    Wang N; Wang Z; Niu X; Yang X
    J Inorg Biochem; 2015 Nov; 152():104-13. PubMed ID: 26383118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
    Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
    J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
    Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
    Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.